CME Group Inc. $CME Shares Sold by Measured Risk Portfolios Inc.

Measured Risk Portfolios Inc. trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME) by 6.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,616 shares of the financial services provider’s stock after selling 500 shares during the period. CME Group makes up about 2.0% of Measured Risk Portfolios Inc.’s portfolio, making the stock its 19th biggest position. Measured Risk Portfolios Inc.’s holdings in CME Group were worth $2,099,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Simplicity Wealth LLC lifted its stake in CME Group by 140.0% during the 2nd quarter. Simplicity Wealth LLC now owns 2,174 shares of the financial services provider’s stock valued at $599,000 after acquiring an additional 1,268 shares during the period. Capital City Trust Co. FL acquired a new stake in CME Group during the 2nd quarter valued at approximately $1,950,000. Boston Common Asset Management LLC lifted its stake in CME Group by 53.2% during the 2nd quarter. Boston Common Asset Management LLC now owns 49,598 shares of the financial services provider’s stock valued at $13,670,000 after acquiring an additional 17,222 shares during the period. Clarius Group LLC lifted its stake in CME Group by 41.2% during the 2nd quarter. Clarius Group LLC now owns 2,338 shares of the financial services provider’s stock valued at $644,000 after acquiring an additional 682 shares during the period. Finally, LGT Fund Management Co Ltd. lifted its stake in CME Group by 26.9% during the 2nd quarter. LGT Fund Management Co Ltd. now owns 33,359 shares of the financial services provider’s stock valued at $9,194,000 after acquiring an additional 7,071 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at CME Group

In related news, General Counsel Jonathan L. Marcus sold 392 shares of the business’s stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel owned 7,851 shares of the company’s stock, valued at approximately $2,056,962. The trade was a 4.76% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the sale, the insider directly owned 9,508 shares of the company’s stock, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock worth $3,527,956 in the last quarter. 0.30% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Piper Sandler lifted their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research note on Tuesday, July 15th. Weiss Ratings reiterated a “buy (b)” rating on shares of CME Group in a research note on Saturday, September 27th. Morgan Stanley boosted their target price on shares of CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a research note on Wednesday. Oppenheimer boosted their target price on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research note on Thursday, July 24th. Finally, Wall Street Zen cut shares of CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Six research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, CME Group has a consensus rating of “Hold” and an average target price of $274.15.

CME Group Price Performance

Shares of NASDAQ CME opened at $264.67 on Friday. The firm has a market cap of $95.38 billion, a PE ratio of 25.62, a PEG ratio of 5.57 and a beta of 0.41. The firm has a fifty day moving average of $269.98 and a 200 day moving average of $271.13. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a one year low of $213.94 and a one year high of $290.79.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm’s revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.56 EPS. As a group, research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s payout ratio is presently 48.40%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.